PINK ETF Guide | Stock Quote, Holdings, Fact Sheet and More (PINK)
Description
The PINK ETF contains 0 constituents. It is focused on growth holdings in the region.
Price $24.26 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | 0.31% |
| Expense ratio | 0.5% |
| Average spread | 0.206% |
| 1Y roundtrip cost | 0.706% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -9.6% | 2.1% | 5.3% | -5.9% | 0.2% | -3.7% | 5.0% | -4.4% | -3.9% | 2.2% | -12.7% | ||
| 2021 | -2.6% | 8.8% | 6.3% | ||||||||||
| -9.6% | 2.1% | 5.3% | -5.9% | 0.2% | -3.7% | 5.0% | -4.4% | -3.9% | 2.2% | -2.6% | 8.8% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0.04 | 0.03 | 0.06 | ||||||||||
| 2021 | 0.01 | 0.01 | |||||||||||
| 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| UnitedHealth Group Incorporated | 8.40% |
| DexCom, Inc. | 5.34% |
| Abbott Laboratories | 4.95% |
| United Therapeutics Corporation | 4.91% |
| Pfizer Inc. | 4.78% |
| Zoetis, Inc. Class A | 4.14% |
| Johnson & Johnson | 3.86% |
| Insulet Corporation | 3.69% |
| Merck & Co., Inc. | 3.54% |
| Anthem, Inc. | 3.24% |
| Eli Lilly and Company | 3.22% |
| Horizon Therapeutics Public Limited Company | 2.98% |
| Edwards Lifesciences Corporation | 2.60% |
| AbbVie, Inc. | 2.54% |
| Stryker Corporation | 2.47% |
| Top 15 Weights | 60.66% |
Compare with similar ETFs
| PINK | |
|---|---|
| Product name | PINK ETF Guide | Stock Quote, Holdings, Fact Sheet and More |
| Issuer | Simplify |
| Price | $24.261 |
| Expense Ratio | 0.5% |
| Average Spread | 0.206% |
| AUM | $3,025,760 |
| Shares | 124,717 |
| Average Daily Volume | 32,090 |
| Home page | Visit external site |
| Inception Date | 2021-10-07 |
| Index Tracked | No Underlying Index |
| Category | Health & Biotech Equities |
| Asset Class | Equity |
| Asset Class Size | |
| Value or Growth | Growth |
| Region | |
| Countries | U.S. |
| Annual Dividend Rate | $0.076 |
| Annual Dividend Yield | 0.003% |
| Number of Holdings | 0 |
| YTD Return | -12.98% |
| Beta | 0.68 |
| Upside Beta | 0.02 |
| Downside Beta | -0.67 |
| Volatility 1Y | 20.89% |
| Sharpe Ratio 3Y | 0.00 |
| Treynor Ratio 3Y | 0.00 |